| Financial Year |
March 31 2023 |
| Monetary Funds |
642,346,295.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
68,720,668.89 |
| Advances to Suppliers |
6,117,846.19 |
| Other Receivables |
3,922,957.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
47,413,566.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,183,838.03 |
| Total Current Assets |
771,705,173.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,262,631.81 |
| Investment Properties |
-- |
| Fixed Assetes |
1,213,133,966.02 |
| Under-construction Projects |
119,494,602.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
121,584,427.70 |
| R&D expenses |
-- |
| Goodwill |
986,746.86 |
| Long-Term Deferred and Prepaid Expenses |
35,831,135.76 |
| Deferred Income Tax Assets |
14,620,943.91 |
| Other Non-Current Assets |
1,636,671.22 |
| Sub-Total of Non-Current Assets |
1,556,083,863.78 |
| Total Assets |
2,327,789,036.86 |
| Short-Term Loans |
20,113,666.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
196,801,373.83 |
| Accounts Received In Advance |
29,294,085.13 |
| Employee Compensation Payable |
29,807,208.82 |
| Taxes Payable |
3,288,794.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,149,128.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,076,165.31 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
313,915,911.75 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,122,867.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
39,729,011.11 |
| Deferred Income Tax Liabilities |
44,642,367.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
110,720,591.93 |
| Total Liabilities |
424,636,503.68 |
| Paid-In Capital(Or Share Stock) |
453,079,583.00 |
| Capital Surplus |
2,744,207,003.01 |
| Surplus Reserve |
25,102,306.36 |
| LESS:Treasury Stock |
48,403,712.60 |
| Undistributed Profits |
-1,271,832,012.89 |
| Minority Stockholder's Interest |
999,366.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,902,153,166.88 |
| Owner's Equity（Stockholder's Equity） |
1,903,152,533.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,327,789,036.86 |
